LPL Financial’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-76,625
| Closed | -$395K | – | 5165 |
|
|
2024
Q2 | $395K | Buy |
76,625
+500
| +0.7% | +$2.58K | ﹤0.01% | 3986 |
|
|
2024
Q1 | $407K | Sell |
76,125
-5,400
| -7% | -$28.9K | ﹤0.01% | 3890 |
|
|
2023
Q4 | $635K | Sell |
81,525
-8,650
| -10% | -$67.4K | ﹤0.01% | 3432 |
|
|
2023
Q3 | $356K | Sell |
90,175
-3,900
| -4% | -$15.4K | ﹤0.01% | 3728 |
|
|
2023
Q2 | $296K | Buy |
94,075
+10,886
| +13% | +$34.3K | ﹤0.01% | 3816 |
|
|
2023
Q1 | $222K | Buy |
83,189
+42,209
| +103% | +$113K | ﹤0.01% | 3937 |
|
|
2022
Q4 | $147K | Buy |
40,980
+29,145
| +246% | +$105K | ﹤0.01% | 4045 |
|
|
2022
Q3 | $76K | Buy |
11,835
+2,121
| +22% | +$13.6K | ﹤0.01% | 4128 |
|
|
2022
Q2 | $94K | Sell |
9,714
-2,400
| -20% | -$23.2K | ﹤0.01% | 4113 |
|
|
2022
Q1 | $144K | Buy |
12,114
+5,108
| +73% | +$60.7K | ﹤0.01% | 3888 |
|
|
2021
Q4 | $228K | Buy |
7,006
+2,294
| +49% | +$74.7K | ﹤0.01% | 3889 |
|
|
2021
Q3 | $211K | Buy |
4,712
+903
| +24% | +$40.4K | ﹤0.01% | 3918 |
|
|
2021
Q2 | $208K | Buy |
3,809
+1,876
| +97% | +$102K | ﹤0.01% | 3858 |
|
|
2021
Q1 | $145K | Buy |
1,933
+531
| +38% | +$39.8K | ﹤0.01% | 3836 |
|
|
2020
Q4 | $152K | Buy |
+1,402
| New | +$152K | ﹤0.01% | 3581 |
|